FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

698091001: Canakinumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2014. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2971724019 Canakinumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2971764015 Canakinumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Canakinumab Is a Monoclonal antibody agent false Inferred relationship Existential restriction modifier
Canakinumab Is a Substance with interleukin 1 receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Canakinumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Canakinumab Has disposition Interleukin 1 receptor antagonist true Inferred relationship Existential restriction modifier
Canakinumab Is a Immunologic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing canakinumab Has active ingredient True Canakinumab Inferred relationship Existential restriction modifier 1
Canakinumab 150mg powder for injection solution Has active ingredient False Canakinumab Inferred relationship Existential restriction modifier
Canakinumab Has active ingredient True Canakinumab Inferred relationship Existential restriction modifier 1
Product containing canakinumab in parenteral dose form (medicinal product form) Has active ingredient True Canakinumab Inferred relationship Existential restriction modifier 1
Product containing precisely canakinumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Canakinumab Inferred relationship Existential restriction modifier 1
Product containing precisely canakinumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Canakinumab Inferred relationship Existential restriction modifier 1
Product containing precisely canakinumab 150 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has basis of strength substance False Canakinumab Inferred relationship Existential restriction modifier 1
Product containing precisely canakinumab 150 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has precise active ingredient False Canakinumab Inferred relationship Existential restriction modifier 1
Product containing only canakinumab in parenteral dose form (medicinal product form) Has active ingredient True Canakinumab Inferred relationship Existential restriction modifier 1
Product containing precisely canakinumab 150 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Canakinumab Inferred relationship Existential restriction modifier 1
Product containing precisely canakinumab 150 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Canakinumab Inferred relationship Existential restriction modifier 1
Canakinumab 150mg powder for solution for injection vials Has active ingredient False Canakinumab Inferred relationship Existential restriction modifier
Ilaris 150mg powder for solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Canakinumab Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials Has specific active ingredient True Canakinumab Inferred relationship Existential restriction modifier
Ilaris 150mg powder for solution for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has specific active ingredient True Canakinumab Inferred relationship Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials 1 vial Has specific active ingredient True Canakinumab Inferred relationship Existential restriction modifier
Canakinumab 150mg/1ml solution for injection vials Has active ingredient False Canakinumab Inferred relationship Existential restriction modifier
Canakinumab 150mg/1ml solution for injection vials Has specific active ingredient True Canakinumab Inferred relationship Existential restriction modifier
Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Canakinumab Inferred relationship Existential restriction modifier
Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Canakinumab Inferred relationship Existential restriction modifier
Canakinumab 150mg/1ml solution for injection vials 1 vial Has specific active ingredient True Canakinumab Inferred relationship Existential restriction modifier
Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has specific active ingredient True Canakinumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start